Is BioLife Sciences (OTCPK: BLFE) An OTC Company Primed For Growth?
HENDERSON, NV, Aug 10, 2022 – BioLife Sciences Inc. (BioLife), a commercialization accelerator, licensor and developer of technologies, has reportedly provided investors with a significant company update throughout the course of a two-year transformation.
